{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Brain tumor", "Cell death", "Cellular engineering", "Cytokine", "Glioma"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32430842", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.1007/s12035-020-01922-5"], "Journal": {"ISSN": "1559-1182", "JournalIssue": {"Volume": "57", "Issue": "8", "PubDate": {"Year": "2020", "Month": "Aug"}}, "Title": "Molecular neurobiology", "ISOAbbreviation": "Mol Neurobiol"}, "ArticleTitle": "Curcumin Loaded in Niosomal Nanoparticles Improved the Anti-tumor Effects of Free Curcumin on Glioblastoma Stem-like Cells: an In Vitro Study.", "Pagination": {"StartPage": "3391", "EndPage": "3411", "MedlinePgn": "3391-3411"}, "Abstract": {"AbstractText": ["Using a novel curcumin-loaded niosome nanoparticle (CM-NP), the present study was designed to evaluate the effect of curcumin on human glioblastoma stem-like cells (GSCs). CM-NP has a diameter of ~ 60\u00a0nm and a zeta potential of ~ - 35\u00a0mV with a constant physicochemical stability. The cytotoxic effects of free curcumin (CM) and CM-NP were investigated on GSCs obtained during the removal of a brain tumor. Both CM and CM-NP caused a dose-dependent decrease in cell proliferation and viability of GSCs. The IC50 values of CM and CM-NP on GSCs were 50 and 137\u00a0\u03bcg/ml after 24\u00a0h, respectively. CM-NP exerted significantly higher effects on GSC viability, apoptosis, cell cycle arrest, and the expression of Bax, a pro-apoptotic marker, compared with CM. In addition, the migration of GSCs was significantly impaired following the administration of CM-NP compared with CM. Furthermore, CM-NP significantly increased the values of reactive oxygen species and decreased the mRNA expressions of NF-\u03baB and IL-6 of GSCs compared with CM. Our data also revealed that CM-NP could significantly reduce the invasiveness of GSCs compared with CM, possibly via MCP-1-mediated pathways. In addition, CM-NP exhibited a significantly greater inhibitory effect on colony formation of GSCs compared with CM. These data indicate that CM-NP exhibited stronger anti-tumor effects on GSCs than CM. Although further in vivo investigations are warranted, our results suggest that CM-NP could be an ideal carrier to deliver curcumin for potential therapeutic approaches into glioblastoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran."}], "LastName": "Sahab-Negah", "ForeName": "Sajad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Ariakia", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jalili-Nik", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Afshari", "ForeName": "Amir R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Nanotechnology, Research Institute of Food Science and Technology, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Materials and Metallurgical Engineering, Materials and Metallurgical Engineering Faculty, Semnan University, Semnan, Iran."}], "LastName": "Salehi", "ForeName": "Sahar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Samini", "ForeName": "Fariborz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Nanotechnology, Research Institute of Food Science and Technology, Mashhad, Iran. Gh.Rajabzadeh@rifast.ac.ir."}], "LastName": "Rajabzadeh", "ForeName": "Ghadir", "Initials": "G"}, {"Identifier": ["0000-0002-4557-3270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. gorjial@uni-muenster.de."}, {"Identifier": [], "Affiliation": "Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. gorjial@uni-muenster.de."}, {"Identifier": [], "Affiliation": "Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran. gorjial@uni-muenster.de."}, {"Identifier": [], "Affiliation": "Department of Neurosurgery and Department of Neurology, Westf\u00e4lische Wilhelms-Universit\u00e4t, 48149, M\u00fcnster, Germany. gorjial@uni-muenster.de."}, {"Identifier": [], "Affiliation": "Epilepsy Research Center, Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster, 48149, M\u00fcnster, Germany. gorjial@uni-muenster.de."}], "LastName": "Gorji", "ForeName": "Ali", "Initials": "A"}], "GrantList": [{"GrantID": "Neuroscience Chair", "Agency": "Iran National Science Foundation", "Country": ""}, {"GrantID": "964650", "Agency": "National Institute for Medical Research Development", "Country": ""}, {"GrantID": "57348208 and 57403633", "Agency": "Deutscher Akademischer Austauschdienst", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mol Neurobiol", "NlmUniqueID": "8900963", "ISSNLinking": "0893-7648"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "genetics"], "DescriptorName": "Brain Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Curcumin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["pathology"], "DescriptorName": "Glioblastoma"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Louis DN, Ohgaki H, Wiestler OD (2007) WHO classification of tumours of the central nervous system, vol 1. WHO Regional Office Europe", "ArticleIdList": ["PMC1929165", "17618441"]}, {"Citation": "Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29(12):1203\u20131217. doi: 10.1101/gad.261982.115.", "ArticleIdList": ["10.1101/gad.261982.115", "PMC4495393", "26109046"]}, {"Citation": "Sattiraju A, Sai KKS, Mintz A (2017) Glioblastoma stem cells and their microenvironment. In: Stem cell microenvironments and beyond. Springer, pp. 119\u2013140", "ArticleIdList": ["29204831"]}, {"Citation": "Kahlert UD, Mooney SM, Natsumeda M, Steiger HJ, Maciaczyk J. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways. Int J Cancer. 2017;140(1):10\u201322. doi: 10.1002/ijc.30259.", "ArticleIdList": ["10.1002/ijc.30259", "27389307"]}, {"Citation": "Sordillo LA, Sordillo PP, Helson L. Curcumin for the treatment of glioblastoma. Anticancer Res. 2015;35(12):6373\u20136378.", "ArticleIdList": ["26637846"]}, {"Citation": "Lee WH, Loo CY, Young PM, Traini D, Mason RS, Rohanizadeh R. Recent advances in curcumin nanoformulation for cancer therapy. Expert Opin Drug Deliv. 2014;11(8):1183\u20131201. doi: 10.1517/17425247.2014.916686.", "ArticleIdList": ["10.1517/17425247.2014.916686", "24857605"]}, {"Citation": "Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003;23(1/A):363\u2013398.", "ArticleIdList": ["12680238"]}, {"Citation": "Agrawal DK, Mishra PK. Curcumin and its analogues: potential anticancer agents. Med Res Rev. 2010;30(5):818\u2013860.", "ArticleIdList": ["20027668"]}, {"Citation": "Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631\u20131652. doi: 10.1007/s00018-008-7452-4.", "ArticleIdList": ["10.1007/s00018-008-7452-4", "PMC4686230", "18324353"]}, {"Citation": "Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11(3):495\u2013510. doi: 10.1208/s12248-009-9128-x.", "ArticleIdList": ["10.1208/s12248-009-9128-x", "PMC2758121", "19590964"]}, {"Citation": "Wu B, Yao H, Wang S, Xu R. DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-\u03baB, and caspase-3 activation. Biochem Biophys Res Commun. 2013;434(1):75\u201380. doi: 10.1016/j.bbrc.2013.03.063.", "ArticleIdList": ["10.1016/j.bbrc.2013.03.063", "23545262"]}, {"Citation": "Guo YQJMX, Cao JSYYB, Zhang L. Curcumin enhances the radiosensitivity of U87 cells by inducing DUSP-2 up-regulation. Cell Physiol Biochem. 2015;35:1381\u20131393. doi: 10.1159/000373959.", "ArticleIdList": ["10.1159/000373959", "25792385"]}, {"Citation": "Pauwels B, Wouters A, Peeters M, Vermorken JB, Lardon F. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation. Future Oncol. 2010;6(9):1485\u20131496. doi: 10.2217/fon.10.104.", "ArticleIdList": ["10.2217/fon.10.104", "20919831"]}, {"Citation": "Senft C, Polacin M, Priester M, Seifert V, Kogel D, Weissenberger J. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer. 2010;10:491. doi: 10.1186/1471-2407-10-491.", "ArticleIdList": ["10.1186/1471-2407-10-491", "PMC2949804", "20840775"]}, {"Citation": "Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH, Kim WK, Kim HS. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun. 2005;335(4):1017\u20131025. doi: 10.1016/j.bbrc.2005.07.174.", "ArticleIdList": ["10.1016/j.bbrc.2005.07.174", "16102725"]}, {"Citation": "Kim S-Y, Jung S-H, Kim H-S. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun. 2005;337(2):510\u2013516. doi: 10.1016/j.bbrc.2005.09.079.", "ArticleIdList": ["10.1016/j.bbrc.2005.09.079", "16198311"]}, {"Citation": "Thani A, Azela N, Sallis B, Nuttall R, Schubert FR, Ahsan M, Davies D, Purewal S, Cooper A, Rooprai HK. Induction of apoptosis and reduction of MMP gene expression in the U373 cell line by polyphenolics in Aronia melanocarpa and by curcumin. Oncol Rep. 2012;28(4):1435\u20131442. doi: 10.3892/or.2012.1941.", "ArticleIdList": ["10.3892/or.2012.1941", "22842701"]}, {"Citation": "Zanotto-Filho A, Braganhol E, Schr\u00f6der R, de Souza LHT, Dalmolin RJ, Pasquali MAB, Gelain DP, Battastini AMO, Moreira JCF. NF\u03baB inhibitors induce cell death in glioblastomas. Biochem Pharmacol. 2011;81(3):412\u2013424. doi: 10.1016/j.bcp.2010.10.014.", "ArticleIdList": ["10.1016/j.bcp.2010.10.014", "21040711"]}, {"Citation": "Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NF\u03baB transcription factors. J Neurochem. 2007;102(2):522\u2013538. doi: 10.1111/j.1471-4159.2007.04633.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04633.x", "17596214"]}, {"Citation": "Leng L, Zhong X, Sun G, Qiu W, Shi L. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo. Tumour Biol. 2016;37:15847\u201315857. doi: 10.1007/s13277-016-5399-x.", "ArticleIdList": ["10.1007/s13277-016-5399-x", "27757851"]}, {"Citation": "Tsai Y-M, Chien C-F, Lin L-C, Tsai T-H. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood\u2013brain barrier penetration. Int J Pharm. 2011;416(1):331\u2013338. doi: 10.1016/j.ijpharm.2011.06.030.", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.030", "21729743"]}, {"Citation": "Ganta S, Amiji M. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm. 2009;6(3):928\u2013939. doi: 10.1021/mp800240j.", "ArticleIdList": ["10.1021/mp800240j", "19278222"]}, {"Citation": "Nair KL, Thulasidasan AK, Deepa G, Anto RJ, Kumar GS. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Int J Pharm. 2012;425(1\u20132):44\u201352. doi: 10.1016/j.ijpharm.2012.01.003.", "ArticleIdList": ["10.1016/j.ijpharm.2012.01.003", "22266528"]}, {"Citation": "Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597\u20136611. doi: 10.1016/j.biomaterials.2010.04.062.", "ArticleIdList": ["10.1016/j.biomaterials.2010.04.062", "20553984"]}, {"Citation": "Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A. 2008;86(2):300\u2013310. doi: 10.1002/jbm.a.31584.", "ArticleIdList": ["10.1002/jbm.a.31584", "17957721"]}, {"Citation": "Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A. Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): a novel strategy for human cancer therapy. J Nanobiotechnol. 2007;5:3. doi: 10.1186/1477-3155-5-3.", "ArticleIdList": ["10.1186/1477-3155-5-3", "PMC1868037", "17439648"]}, {"Citation": "Zhao M, Zhao M, Fu C, Yu Y, Fu A. Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes. Int J Nanomedicine. 2018;13:1601\u20131610. doi: 10.2147/IJN.S157019.", "ArticleIdList": ["10.2147/IJN.S157019", "PMC5858816", "29588587"]}, {"Citation": "Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011;11(5):464\u2013473. doi: 10.4161/cbt.11.5.14410.", "ArticleIdList": ["10.4161/cbt.11.5.14410", "PMC3087900", "21193839"]}, {"Citation": "Lim KJ, Maitra A, Bisht S, Eberhart C, Bar E (2010) Using nanocurcumin to treat medulloblastoma and glioblastoma. AACR"}, {"Citation": "Srinivas S, Kumar YA, Hemanth A, Anitha M. Preparation and evaluation of niosomes containing aceclofenac. Dig J Nanomater Bios. 2010;5(1):249\u2013254."}, {"Citation": "Bartelds R, Nematollahi MH, Pols T, Stuart MCA, Pardakhty A, Asadikaram G, Poolman B. Niosomes, an alternative for liposomal delivery. PLoS One. 2018;13(4):e0194179. doi: 10.1371/journal.pone.0194179.", "ArticleIdList": ["10.1371/journal.pone.0194179", "PMC5896898", "29649223"]}, {"Citation": "Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018;2018:6847971\u20136847915. doi: 10.1155/2018/6847971.", "ArticleIdList": ["10.1155/2018/6847971", "PMC6311792", "30651728"]}, {"Citation": "Basiri L, Rajabzadeh G, Bostan A. Physicochemical properties and release behavior of Span 60/Tween 60 niosomes as vehicle for \u03b1-Tocopherol delivery. LWT. 2017;84:471\u2013478. doi: 10.1016/j.lwt.2017.06.009.", "ArticleIdList": ["10.1016/j.lwt.2017.06.009"]}, {"Citation": "Sharma V, Anandhakumar S, Sasidharan M. Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: an efficient carrier for cancer multi-drug delivery. Mater Sci Eng C Mater Biol Appl. 2015;56:393\u2013400. doi: 10.1016/j.msec.2015.06.049.", "ArticleIdList": ["10.1016/j.msec.2015.06.049", "26249606"]}, {"Citation": "Anitha A, Deepagan V, Rani VD, Menon D, Nair S, Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate\u2013chitosan nanoparticles. Carbohydr Polym. 2011;84(3):1158\u20131164. doi: 10.1016/j.carbpol.2011.01.005.", "ArticleIdList": ["10.1016/j.carbpol.2011.01.005"]}, {"Citation": "Liao Z-X, Li Y-C, Lu H-M, Sung H-W. A genetically-encoded KillerRed protein as an intrinsically generated photosensitizer for photodynamic therapy. Biomaterials. 2014;35(1):500\u2013508. doi: 10.1016/j.biomaterials.2013.09.075.", "ArticleIdList": ["10.1016/j.biomaterials.2013.09.075", "24112805"]}, {"Citation": "Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer. 2001;91(4):822\u2013832. doi: 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G.", "ArticleIdList": ["10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G", "11241252"]}, {"Citation": "Wang X, Deng J, Yuan J, Tang X, Wang Y, Chen H, Liu Y, Zhou L. Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells. Int J Oncol. 2017;51(2):467\u2013477. doi: 10.3892/ijo.2017.4037.", "ArticleIdList": ["10.3892/ijo.2017.4037", "PMC5505128", "28627598"]}, {"Citation": "Negah SS, Khaksar Z, Aligholi H, Sadeghi SM, Mousavi SMM, Kazemi H, Jahan-Abad AJ, Gorji A. Enhancement of neural stem cell survival, proliferation, migration, and differentiation in a novel self-assembly peptide nanofibber scaffold. Mol Neurobiol. 2017;54(10):8050\u20138062. doi: 10.1007/s12035-016-0295-3.", "ArticleIdList": ["10.1007/s12035-016-0295-3", "27878763"]}, {"Citation": "Chen J. The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb Perspect Med. 2016;6(3):a026104. doi: 10.1101/cshperspect.a026104.", "ArticleIdList": ["10.1101/cshperspect.a026104", "PMC4772082", "26931810"]}, {"Citation": "Xia Y, Shen S, Verma IM. NF-kappaB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823\u2013830. doi: 10.1158/2326-6066.CIR-14-0112.", "ArticleIdList": ["10.1158/2326-6066.CIR-14-0112", "PMC4155602", "25187272"]}, {"Citation": "Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep. 2018;8(1):2039. doi: 10.1038/s41598-018-20179-6.", "ArticleIdList": ["10.1038/s41598-018-20179-6", "PMC5794879", "29391517"]}, {"Citation": "Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro-oncology. 2008;10(3):254\u2013264. doi: 10.1215/15228517-2008-001.", "ArticleIdList": ["10.1215/15228517-2008-001", "PMC2563048", "18359864"]}, {"Citation": "Iacopino F, Angelucci C, Piacentini R, Biamonte F, Mangiola A, Maira G, Grassi C, Sica G. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones. PLoS One. 2014;9(8):e105166. doi: 10.1371/journal.pone.0105166.", "ArticleIdList": ["10.1371/journal.pone.0105166", "PMC4133365", "25121761"]}, {"Citation": "Wang H, Agarwal P, Zhao S, Yu J, Lu X, He X. Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells. Biomaterials. 2016;97:62\u201373. doi: 10.1016/j.biomaterials.2016.04.030.", "ArticleIdList": ["10.1016/j.biomaterials.2016.04.030", "PMC4957695", "27162075"]}, {"Citation": "Tran S, DeGiovanni PJ, Piel B, Rai P. Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med. 2017;6(1):44. doi: 10.1186/s40169-017-0175-0.", "ArticleIdList": ["10.1186/s40169-017-0175-0", "PMC5725398", "29230567"]}, {"Citation": "Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar GL (2019) Curcumin and solid lipid curcumin particles induce autophagy, but inhibit mitophagy and the PI3K-Akt/mTOR pathway in cultured glioblastoma cells. Int J Mol Sci 20(2). 10.3390/ijms20020399", "ArticleIdList": ["PMC6359162", "30669284"]}, {"Citation": "Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374\u2013380. doi: 10.4103/0110-5558.76435.", "ArticleIdList": ["10.4103/0110-5558.76435", "PMC3255404", "22247876"]}, {"Citation": "Okore VC, Attama AA, Ofokansi KC, Esimone CO, Onuigbo EB. Formulation and evaluation of niosomes. Indian J Pharm Sci. 2011;73(3):323\u2013328. doi: 10.4103/0250-474X.93515.", "ArticleIdList": ["10.4103/0250-474X.93515", "PMC3309657", "22457561"]}, {"Citation": "Langone P, Debata PR, Inigo Jdel R, Dolai S, Mukherjee S, Halat P, Mastroianni K, Curcio GM, Castellanos MR, Raja K, Banerjee P. Coupling to a glioblastoma-directed antibody potentiates antitumor activity of curcumin. Int J Cancer. 2014;135(3):710\u2013719. doi: 10.1002/ijc.28555.", "ArticleIdList": ["10.1002/ijc.28555", "24142484"]}, {"Citation": "Gharbavi M, Amani J (2018) Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. 2018:6847971\u20136847915. 10.1155/2018/6847971", "ArticleIdList": ["PMC6311792", "30651728"]}, {"Citation": "van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1\u201312. doi: 10.1016/j.drup.2015.02.002.", "ArticleIdList": ["10.1016/j.drup.2015.02.002", "25791797"]}, {"Citation": "Zanotto-Filho A, Coradini K, Braganhol E, Schroder R, de Oliveira CM, Simoes-Pires A, Battastini AM, Pohlmann AR, Guterres SS, Forcelini CM, Beck RC, Moreira JC. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment. Eur J Pharm Biopharm. 2013;83(2):156\u2013167. doi: 10.1016/j.ejpb.2012.10.019.", "ArticleIdList": ["10.1016/j.ejpb.2012.10.019", "23219677"]}, {"Citation": "Bragagni M, Mennini N, Furlanetto S, Orlandini S, Ghelardini C, Mura P. Development and characterization of functionalized niosomes for brain targeting of dynorphin-B. Eur J Pharm Biopharm. 2014;87(1):73\u201379. doi: 10.1016/j.ejpb.2014.01.006.", "ArticleIdList": ["10.1016/j.ejpb.2014.01.006", "24462793"]}, {"Citation": "Gersey ZC, Rodriguez GA, Barbarite E, Sanchez A, Walters WM, Ohaeto KC, Komotar RJ, Graham RM. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer. 2017;17(1):99. doi: 10.1186/s12885-017-3058-2.", "ArticleIdList": ["10.1186/s12885-017-3058-2", "PMC5292151", "28160777"]}, {"Citation": "Shin HJ, Lee S, Jung HJ. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca(2+) /calmodulin-dependent protein kinase II. J Cell Biochem. 2019;120(4):6741\u20136752. doi: 10.1002/jcb.27972.", "ArticleIdList": ["10.1002/jcb.27972", "30390339"]}, {"Citation": "Wang Y, Ying X, Xu H, Yan H, Li X, Tang H. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. Int J Nanomedicine. 2017;12:1369\u20131384. doi: 10.2147/IJN.S124276.", "ArticleIdList": ["10.2147/IJN.S124276", "PMC5325138", "28260885"]}, {"Citation": "Mukherjee S, Fried A, Hussaini R, White R, Baidoo J, Yalamanchi S, Banerjee P. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. J Exp Clin Cancer Res. 2018;37(1):168. doi: 10.1186/s13046-018-0792-5.", "ArticleIdList": ["10.1186/s13046-018-0792-5", "PMC6058381", "30041669"]}, {"Citation": "Fong D, Yeh A, Naftalovich R, Choi TH, Chan MM. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals. Cancer Lett. 2010;293(1):65\u201372. doi: 10.1016/j.canlet.2009.12.018.", "ArticleIdList": ["10.1016/j.canlet.2009.12.018", "PMC2862867", "20089354"]}, {"Citation": "Zhuang W, Long L, Zheng B, Ji W, Yang N, Zhang Q, Liang Z. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci. 2012;103(4):684\u2013690. doi: 10.1111/j.1349-7006.2011.02198.x.", "ArticleIdList": ["10.1111/j.1349-7006.2011.02198.x", "PMC7659256", "22192169"]}, {"Citation": "Zhang Y, Dube C, Gibert M Jr, Cruickshanks N, Wang B, Coughlan M, Yang Y, Setiady I et al (2018) The p53 pathway in glioblastoma. Cancers 10(9). 10.3390/cancers10090297", "ArticleIdList": ["PMC6162501", "30200436"]}, {"Citation": "Touat M, Idbaih A, Sanson M, Ligon KL. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol. 2017;28(7):1457\u20131472. doi: 10.1093/annonc/mdx106.", "ArticleIdList": ["10.1093/annonc/mdx106", "PMC5834086", "28863449"]}, {"Citation": "Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3\u2032-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30(4):905\u2013918.", "ArticleIdList": ["17332930"]}, {"Citation": "Talib WH, Al-Hadid SA, Ali MBW, Al-Yasari IH, Ali MRA. Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action. Breast Cancer (Dove Medical Press) 2018;10:207\u2013217. doi: 10.2147/BCTT.S167812.", "ArticleIdList": ["10.2147/BCTT.S167812", "PMC6276637", "30568488"]}, {"Citation": "Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, Lee PW, Giacomantonio CA, Hoskin DW. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett. 2010;297(1):1\u20138. doi: 10.1016/j.canlet.2010.04.018.", "ArticleIdList": ["10.1016/j.canlet.2010.04.018", "20472336"]}, {"Citation": "Fels C, Schafer C, Huppe B, Bahn H, Heidecke V, Kramm CM, Lautenschlager C, Rainov NG. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. J Neuro-Oncol. 2000;48(3):207\u2013216. doi: 10.1023/A:1006484801654.", "ArticleIdList": ["10.1023/A:1006484801654", "11100818"]}, {"Citation": "Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT, Jezequel P, Meflah K, Vallette FM. The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet. 2002;11(6):675\u2013687. doi: 10.1093/hmg/11.6.675.", "ArticleIdList": ["10.1093/hmg/11.6.675", "11912183"]}, {"Citation": "Karmakar S, Banik NL, Ray SK. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res. 2007;32(12):2103\u20132113. doi: 10.1007/s11064-007-9376-z.", "ArticleIdList": ["10.1007/s11064-007-9376-z", "17562168"]}, {"Citation": "Fan Y, Dutta J, Gupta N, Fan G, Gelinas C. Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy. Adv Exp Med Biol. 2008;615:223\u2013250. doi: 10.1007/978-1-4020-6554-5_11.", "ArticleIdList": ["10.1007/978-1-4020-6554-5_11", "18437897"]}, {"Citation": "Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y. Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-kappaB/COX-2 signaling pathways. OncoTargets Ther. 2017;10:5471\u20135482. doi: 10.2147/OTT.S149708.", "ArticleIdList": ["10.2147/OTT.S149708", "PMC5695266", "29180881"]}, {"Citation": "Rinaldi M, Caffo M, Minutoli L, Marini H, Abbritti RV, Squadrito F, Trichilo V, Valenti A et al (2016) ROS and brain gliomas: an overview of potential and innovative therapeutic strategies. Int J Mol Sci 17(6). 10.3390/ijms17060984", "ArticleIdList": ["PMC4926513", "27338365"]}, {"Citation": "Wang M, Wang T, Liu S, Yoshida D, Teramoto A. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol. 2003;20(2):65\u201372. doi: 10.1007/BF02483449.", "ArticleIdList": ["10.1007/BF02483449", "14756443"]}, {"Citation": "Sciume G, Santoni A, Bernardini G. Chemokines and glioma: invasion and more. J Neuroimmunol. 2010;224(1\u20132):8\u201312. doi: 10.1016/j.jneuroim.2010.05.019.", "ArticleIdList": ["10.1016/j.jneuroim.2010.05.019", "20656128"]}, {"Citation": "See AL, Chong PK, Lu SY, Lim YP. CXCL3 is a potential target for breast cancer metastasis. Curr Cancer Drug Targets. 2014;14(3):294\u2013309. doi: 10.2174/1568009614666140305222328.", "ArticleIdList": ["10.2174/1568009614666140305222328", "24605943"]}, {"Citation": "Gui SL, Teng LC, Wang SQ, Liu S, Lin YL, Zhao XL, Liu L, Sui HY, Yang Y, Liang LC, Wang ML, Li XY, Cao Y, Li FY, Wang WQ. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer. Int Urol Nephrol. 2016;48(5):701\u2013709. doi: 10.1007/s11255-016-1222-2.", "ArticleIdList": ["10.1007/s11255-016-1222-2", "26837773"]}, {"Citation": "Dwyer J, Hebda JK, Le Guelte A, Galan-Moya EM, Smith SS, Azzi S, Bidere N, Gavard J. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS One. 2012;7(9):e45562. doi: 10.1371/journal.pone.0045562.", "ArticleIdList": ["10.1371/journal.pone.0045562", "PMC3447807", "23029099"]}, {"Citation": "Bradshaw A, Wickremsekera A, Tan ST, Peng L, Davis PF, Itinteang T. Cancer stem cell hierarchy in glioblastoma multiforme. Front Surg. 2016;3:21. doi: 10.3389/fsurg.2016.00021.", "ArticleIdList": ["10.3389/fsurg.2016.00021", "PMC4831983", "27148537"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "9"}, {"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32430842", "PMC7340659", "10.1007/s12035-020-01922-5", "10.1007/s12035-020-01922-5"]}}]}